» Articles » PMID: 15304844

Multiple Brain Metastases from a Diffuse Sclerosing Variant of Papillary Carcinoma of the Thyroid

Overview
Journal Endocr Pathol
Specialties Endocrinology
Pathology
Date 2004 Aug 12
PMID 15304844
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We report a 53-yr-old man who presented with multiple brain metastases from a diffuse sclerosing papillary carcinoma of the thyroid. The presenting clinical features were those of an intracranial space-occupying lesion. Three brain tumors, confirmed pathologically to be metastatic thyroid papillary carcinomas, were removed. Two weeks after craniotomy, total thyroidectomy with cervical lymph node dissection was performed. Both lobes of the thyroid were diffusely enlarged and firm with a dominant mass. Histologically, the tumor was characterized by a combination of bilateral diffuse involvement of the gland, marked fibrosis, squamous metaplasia, abundant psammoma bodies, lymphocytic infiltration, frequent lymphatic and blood vessel permeation of the tumor, and typical elements of a conventional papillary carcinoma. In addition to these histologic findings, elements of other papillary carcinoma variants such as follicular and tall cell variants were also found focally. Twenty-three of twenty-four resected bilateral lymph nodes showed metastases of papillary carcinoma. Although the diffuse sclerosing variant of papillary carcinoma of the thyroid seems to be recognized as an aggressive variant of papillary carcinoma, there is no previous report of brain metastasis from this variant.

Citing Articles

Shear wave elastography diagnosis of the diffuse sclerosing variant of papillary thyroid carcinoma: A case report.

Xue N, Xu Y, Huang P, Zhang S, Wang H, Yu F Mol Clin Oncol. 2016; 5(2):333-336.

PMID: 27446574 PMC: 4950890. DOI: 10.3892/mco.2016.932.


Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.

Akaishi J, Sugino K, Kameyama K, Masaki C, Matsuzu K, Suzuki A World J Surg. 2015; 39(7):1728-35.

PMID: 25743484 DOI: 10.1007/s00268-015-3021-9.


Estrogen receptor- and progesterone receptor-positive diffuse sclerosing variant of papillary thyroid carcinoma: a case report.

Kinoshita Y, Takasu K, Yuri T, Yoshizawa K, Emoto Y, Tsubura A Case Rep Oncol. 2013; 6(1):216-23.

PMID: 23626564 PMC: 3636970. DOI: 10.1159/000350784.


Brain metastases from papillary thyroid carcinomas.

Tahmasebi F, Farmer P, Powell S, Aldape K, Fuller G, Patel S Virchows Arch. 2013; 462(4):473-80.

PMID: 23532501 DOI: 10.1007/s00428-013-1394-4.


Diagnosis and treatment of pancreatic metastases of a papillary thyroid carcinoma.

Borschitz T, Eichhorn W, Fottner C, Hansen T, Schad A, Schadmand-Fischer S Thyroid. 2009; 20(1):93-8.

PMID: 20025539 PMC: 2833176. DOI: 10.1089/thy.2009.0026.


References
1.
Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W . Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol. 1988; 89(3):295-300. DOI: 10.1093/ajcp/89.3.295. View

2.
Moreno Egea A, Rodriguez Gonzalez J, Sola Perez J, Soria T, Parrilla Paricio P . Clinicopathological study of the diffuse sclerosing variety of papillary cancer of the thyroid. Presentation of 4 new cases and review of the literature. Eur J Surg Oncol. 1994; 20(1):7-11. View

3.
Lin K, Lin J, Huang H, Jeng L, Ho Y . Skull metastasis with brain invasion from thyroid papillary microcarcinoma. J Formos Med Assoc. 1997; 96(4):280-2. View

4.
SAMAAN N, Schultz P, HICKEY R, Goepfert H, HAYNIE T, Johnston D . The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992; 75(3):714-20. DOI: 10.1210/jcem.75.3.1517360. View

5.
Soares J, Limbert E, Sobrinho-Simoes M . Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases. Pathol Res Pract. 1989; 185(2):200-6. DOI: 10.1016/S0344-0338(89)80252-3. View